Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 31 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (15)
Early P 1 (1)
P 1 (1)
P 2 (3)

Trial Status

Recruiting12
Completed9
Unknown4
Withdrawn3
Not Yet Recruiting2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT04801108Not ApplicableRecruitingPrimary

Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema

NCT05257681Not ApplicableRecruitingPrimary

Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction

NCT05854550Not ApplicableCompletedPrimary

First in Human Study to Assess an Implant to Treat Severe Emphysema

NCT05949645Not ApplicableActive Not RecruitingPrimary

Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema

NCT07119229Not ApplicableNot Yet RecruitingPrimary

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

NCT06035120Not ApplicableRecruiting

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

NCT04517916CompletedPrimary

Zephyr Etude Post-Inscription (French Registry)

NCT06505603Recruiting

PiMZ Longitudinal Cohort (PiMZ Logic)

NCT03500731Phase 1Recruiting

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

NCT06149494Phase 2Completed

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

NCT06068647Not ApplicableRecruiting

Ultrasound and Respiratory Physiological Signals in Lung Diseases

NCT06788613Not Yet Recruiting

Utilising Hull Lung Health Study Data to Investigate the Performance of TidalSense Diagnostic Algorithms to Identify COPD and Pre-COPD Among Participants in the FRONTIER Programme.

NCT05567562Phase 2Completed

Anti-Platelets in Chronic Obstructive Pulmonary Disease

NCT03318406RecruitingPrimary

Post-Market BTVA Registry

NCT06655428Not ApplicableRecruitingPrimary

The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

NCT05900544Not ApplicableWithdrawn

Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures

NCT06000696Completed

Healthy At Home Pilot

NCT03679598Phase 2Completed

Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

NCT06304207Not ApplicableRecruiting

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

NCT04214587RecruitingPrimary

Biological Investigation of Explanted Endobronchial Lung Valves Study

Scroll to load more

Research Network

Activity Timeline